semaglutide and pregnant & Pregnancy: GLP-1s & Fertility pregnant while taking semaglutide Why

For weight management, combining GLP-1 receptor agonists with other anti-obesity medications is generally considered off-label with limited evidence and should be directed by specialists

And skipping it, for someone already at risk of nutritional dilution, has real physiological consequences

Gastro-oesophageal reflux disease (GORD) causes stomach acid to flow back into the oesophagus, leading to heartburn and discomfort

She said: "Trends like this are very dangerous for young people in a stage of growth because limiting nutrients can negatively impact physical development and cognitive health

Missing a single GLP-1 (glucagon-like peptide-1) receptor agonist injection is a common occurrence and typically does not cause immediate harm

Its use in the UK would therefore constitute off-label prescribing at best, or unlicensed importation in most practical scenarios